About Vanqua Bio
Vanqua Bio is a private company based in Chicago, Illinois. It has reported $135,979,974 raised in three offerings on Form D since October 2019. Its chief executive is James Sullivan.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 15, 2024 | Jul 5, 2024 | $44,979,987fully sold | 12 | $3.7M | EquityRule 506(b) | Form D ↗ |
| Aug 27, 2021 | Sep 15, 2021 | $84,999,987fully sold | 11 | $7.7M | EquityRule 506(b) | Form D ↗ |
| Sep 20, 2019 | Oct 7, 2019 | $6,000,000of $18.0M target | 1 | $6.0M | Equity, Series A Preferred StockRule 506(b) | Form D ↗ |
| Total, three offerings | $135,979,974 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Vanqua Bio's Form D filed Jul 5, 2024.
JS
Jonathan Silverstein
Director
RS
Rand Sutherland
Director
BD
Bernard Davitian
Director
UC
Uya Chuluunbaatar
Director
JS
James Sullivan
Chief Executive Officer and director
MA
Earlier filings also listed Viola Meehan (executive officer, last listed Sep 2021), Stephen Squinto (director, last listed Sep 2021) and Sara Nayeem (director, last listed Sep 2021).